ROG.SW CHMP opinion: Thursday, July 23, 2026
Variation type II · Vabysmo · Update of sections 4.2 and 5.1 of the SmPC in order to update posology recommendations to allow for extended intervals of up to every 20 weeks (Q20W) in neovascular (wet) age-related macular degeneration (nAMD) patients with stabilized disease. This proposal is primaril
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.